- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Rhythm Pharmaceuticals Inc (1RV)
Rhythm Pharmaceuticals Inc stock price live, this page displays NASDAQ RYTM stock exchange data. View the RYTM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Rhythm Pharmaceuticals Inc real time stock price chart below.
What Is the Rhythm Pharmaceuticals Inc Stock Price Today?
The Rhythm Pharmaceuticals Inc stock price today is 73.00.
What Is the Stock Symbol for Rhythm Pharmaceuticals Inc?
The stock symbol for Rhythm Pharmaceuticals Inc is ""RYTM.""
What Stock Exchange Does Rhythm Pharmaceuticals Inc Trade On?
Rhythm Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Rhythm Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Rhythm Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RYTM quote. (ISIN: US76243J1051)
What Is the Rhythm Pharmaceuticals Inc Stock Price Today?
The Rhythm Pharmaceuticals Inc stock price today is 73.00.
What Is the Stock Symbol for Rhythm Pharmaceuticals Inc?
The stock symbol for Rhythm Pharmaceuticals Inc is ""RYTM.""
What Stock Exchange Does Rhythm Pharmaceuticals Inc Trade On?
Rhythm Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Rhythm Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Rhythm Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RYTM quote. (ISIN: US76243J1051)
73.00
-0.50(-0.68%)
Closed·
Fair Value
An estimate of a Rhythm Pharmaceuticals Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
73.00
73.00
52 wk Range
39.00
81.50
1RV is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Rhythm Pharmaceuticals Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
73.0073.00
52 wk Range
39.0081.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
1RV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Rhythm Pharmaceuticals Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Currently not supported.
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Rhythm Pharmaceuticals Inc Company Profile
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company’s lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; joint research collaboration with Axovia Therapeutics for developing in bardet-biedl syndrome; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. The company was founded in 2008 and is headquartered in Boston, Massachusetts.
Compare 1RV to Peers and Sector
Metrics to compare | 1RV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1RVPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −1.6x | −0.5x | |
PEG Ratio | 0.00 | −0.03 | 0.00 | |
Price/Book | 0.0x | 2.3x | 2.6x | |
Price / LTM Sales | 0.0x | 37.6x | 3.3x | |
Upside (Analyst Target) | 0.0% | 316.7% | 45.1% | |
Fair Value Upside | Unlock | 27.1% | 7.4% | Unlock |
People Also Watch
FAQ
What Stock Exchange Does Rhythm Pharmaceuticals Inc Trade On?
Rhythm Pharmaceuticals Inc is listed and trades on the Frankfurt Stock Exchange stock exchange.
What Is the Stock Symbol for Rhythm Pharmaceuticals Inc?
The stock symbol for Rhythm Pharmaceuticals Inc is "1RV."
What Is the Rhythm Pharmaceuticals Inc Market Cap?
As of today, Rhythm Pharmaceuticals Inc market cap is 5.01B.
What Is Rhythm Pharmaceuticals Inc's Earnings Per Share (TTM)?
The Rhythm Pharmaceuticals Inc EPS (TTM) is 0.00.
From a Technical Analysis Perspective, Is 1RV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Rhythm Pharmaceuticals Inc Stock Split?
Rhythm Pharmaceuticals Inc has split 0 times.
What is the current trading status of Rhythm Pharmaceuticals Inc (1RV)?
As of 04 Aug 2025, Rhythm Pharmaceuticals Inc (1RV) is trading at a price of 73.00, with a previous close of 76.50. The stock has fluctuated within a day range of 73.00 to 73.00, while its 52-week range spans from 39.00 to 81.50.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.